CVRX Inc.
CVRX Inc. is listed today as CVRx, Inc.: market value, financials and filings are on its company page.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2020 | $50 M | No. 3 | $50 to $250 million | equity | SEC | |
| May 2016 | $75 M | No. 2 | $50 to $250 million | equity | SEC | |
| Jun 2013 | $30 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
CVRX Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2020).
SEC Form D · Jul 2020
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jul 2020
That is all the official record says: CVRX Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of CVRX Inc. are on record.
Investors#
5 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| GSK PLC | Fund or asset manager | not stated | not stated | Held Series B-2, C-2, D-2, E-2, F-2 and G preferred (Form 3, 2021) | SEC Form 3 |
| John Brintnall | Person | not stated | not stated | Held Series F-2 and G preferred stock (Form 3, 2021) | SEC Form 3 |
| Johnson & Johnson Development Corp Et Al | Company | not stated | not stated | Held Series D-2, E-2, F-2 and G preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Nea Partners 10 L.P. | Fund or asset manager | not stated | not stated | Held Series A-2, B-2, C-2, D-2, E-2, F-2 and G preferred (Form 3, 2021) | SEC Form 3 |
| New Enterprise Associates 10 L.P. | Fund or asset manager | not stated | not stated | Held Series A-2, B-2, C-2, D-2, E-2, F-2 and G preferred (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 21 investors.
Largest shareholders today
Institutions holding CVRx, Inc. shares, as of Sep 30, 2026.
- Johnson & Johnson$7 M14.13%
- NEA Management Company, LLC$3 M6.86%
- BlackRock, Inc.$2 M4.52%
- GSK plc$2 M3.54%
- Vanguard Capital Management LLC$2 M3.17%
- Citadel Advisors LLC$1 M2.29%
- Royal Bank Of Canada$1 M1.81%
- Renaissance Technologies LLC$1 M1.53%
- Geode Capital Management, LLC$1 M1.49%
- Goldman Sachs Group Inc$1 M1.31%
- State Street Corp$1 M1.22%
- Morgan Stanley$0 M0.96%
- First Eagle Investment Management, LLC$0 M0.78%
- Tudor Investment Corp Et Al$0 M0.73%
- D. E. Shaw & Co., Inc.$0 M0.70%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Dean Bruhn-Ding | Executive officer | Jul 2020 |
| Elizabeth Galle | Executive officer | Jul 2020 |
| John Brintnall | Executive officer | Jul 2020 |
| Nadim Yared | Executive officer | Jul 2020 |
| Craig M. Palmer | Executive officer | May 2019 |
| Liz Galle | Executive officer | May 2019 |
| Joseph DuPay | Executive officer | May 2018 |
| Tom M. Moore | Executive officer | May 2018 |
| Tom Jay Moore | Executive officer | May 2017 |
| Philippe Wanstok | Executive officer | Jun 2016 |
| Robert Kieval | Executive officer | Jun 2016 |
| Ali M. Behbahani | Director | Jul 2020 |
| Geoff M. Pardo | Director | Jul 2020 |
| John M. Nehra | Director | Jul 2020 |
| Joseph M. Slattery | Director | Jul 2020 |
| Kadir M. Kadhiresan | Director | Jul 2020 |
| Kirk K. Nielsen | Director | Jul 2020 |
| Mudit K. Jain | Director | Jul 2020 |
| Nadim Yared | Director | Jul 2020 |
| Tom M. Heyman | Director | May 2019 |
| A. Jay Graf | Director | May 2017 |
| Ali Jay Behbahani | Director | May 2017 |
| Geoff Jay Pardo | Director | May 2017 |
| Joseph Jay Slattery | Director | May 2017 |
| Kadir Jay Kadhiresan | Director | May 2017 |
| Tom Jay Heyman | Director | May 2017 |
| Ali Ll Behbahani | Director | Jun 2016 |
| Josep Ll Sanfeliu | Director | Jun 2016 |
| Joseph Ll Slattery | Director | Jun 2016 |
| Mike Ll Chuisano | Director | Jun 2016 |
| Robert Kieval | Director | Jun 2016 |
| John Jay Nehra | Director | Jul 2013 |
| Mike Jay Chuisano | Director | Jul 2013 |
About
Company in Minneapolis, United States.
Went public since 2021. Its SEC number is that of a company listed on a stock exchange.